Laman UtamaEVGN • NASDAQ
add
Evogene Ltd
$1.38
Selepas Waktu Dagangan:(0.72%)+0.0100
$1.39
Tutup: 13 Jun, 7:40:35 PTG GMT-4 · USD · NASDAQ · Penafian
Tutup sebelumnya
$1.52
Julat hari
$1.34 - $1.55
Julat tahun
$0.95 - $7.19
Permodalan pasaran
9.21J USD
Bilangan Purata
3.63J
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Berita pasaran
FinanceFeeds
1 hari lalu
S&P 500 Menembus Aliran Naik Di Tengah Ketegangan Timur Tengah yang Meningkat
1.79%
1.13%
1.20%
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Mac 2025info | Perubahan T/T |
|---|---|---|
Hasil | 2.44J | -41.67% |
Perbelanjaan pengendalian | 4.96J | -33.45% |
Pendapatan bersih | -2.59J | 33.03% |
Margin untung bersih | -105.85 | -14.80% |
Pendapatan bagi setiap syer | -0.38 | 52.50% |
EBITDA | -3.55J | -22.48% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Mac 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 9.85J | -62.99% |
Jumlah aset | 34.30J | -26.67% |
Jumlah liabiliti | 21.91J | 2.39% |
Jumlah ekuiti | 12.40J | — |
Syer tertunggak | 6.67J | — |
Harga kepada buku | -2.76 | — |
Pulangan pada aset | -27.82% | — |
Pulangan pada modal | -63.81% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Mac 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -2.59J | 33.03% |
Tunai daripada operasi | -5.18J | -26.08% |
Tunai daripada pelaburan | -2.45J | 43.92% |
Tunai daripada pembiayaan | -159.00K | 56.68% |
Perubahan bersih dalam tunai | -7.81J | 11.87% |
Aliran tunai bebas | -5.32J | -80.72% |
Perihal
Evogene is a computational biology company based in Israel, specializing in predictive biology platforms that leverage artificial intelligence and machine learning for life-science product development. Evogene's platforms focus on designing novel microbes, small molecules, and genetic elements for use in pharmaceuticals, agriculture, and related industries. In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
CEO
Diasaskan
2002
Tapak web
Pekerja
117
